Latent (slowly progressing) autoimmune diabetes in adults.

Abstract:

:About 10% of patients with the clinical presentation of type 2 diabetes suffer from an autoimmune form of diabetes associated with a rapid decline of residual beta-cell mass and subsequent development of insulin dependency. In this condition, called latent autoimmune diabetes in adults (LADA), there are clinical and metabolic features intermediate between type 1 and type 2 diabetes. Recent studies provide novel information on the immune markers associated with progressive beta-cell loss in LADA patients. However, LADA pathogenesis is still poorly understood; further studies are needed to establish general recommendation for preventing and treating this subtype of autoimmune diabetes.

journal_name

Curr Diab Rep

journal_title

Current diabetes reports

authors

Seissler J

doi

10.1007/s11892-008-0018-x

subject

Has Abstract

pub_date

2008-04-01 00:00:00

pages

94-100

issue

2

eissn

1534-4827

issn

1539-0829

journal_volume

8

pub_type

杂志文章,评审
  • Diabetic foot disease in people with advanced nephropathy and those on renal dialysis.

    abstract::Among the spectrum of risk for diabetic foot disease conferred by chronic kidney disease (CKD), end-stage renal disease (ESRD) has emerged as a novel independent risk factor. Apart from the classical triad of neuropathy, infection, and peripheral arterial disease that operate in these individuals, the risk is further ...

    journal_title:Current diabetes reports

    pub_type: 杂志文章,评审

    doi:10.1007/s11892-010-0128-0

    authors: Ndip A,Lavery LA,Boulton AJ

    更新日期:2010-08-01 00:00:00

  • Role of Senescent Renal Cells in Pathophysiology of Diabetic Kidney Disease.

    abstract:PURPOSE OF REVIEW:Diabetic kidney disease (DKD) is the leading cause of kidney failure in the USA, representing ~ 44% of all cases of kidney failure. Advancements in both glucose management and inhibitors of the renin-angiotensin system have significantly improved prognosis for individuals with DKD, yet DKD continues t...

    journal_title:Current diabetes reports

    pub_type: 杂志文章,评审

    doi:10.1007/s11892-020-01314-y

    authors: Wiley CD

    更新日期:2020-06-16 00:00:00

  • National Strategies to Decrease the Burden of Diabetes and Its Complications.

    abstract::Comparative results from national strategies for diabetes care and prevention are needed to understand the impact and barriers encountered during the implementation process. Long-term outcomes are limited, but results on intermediate outcomes and processes of diabetes care measures are available from translational res...

    journal_title:Current diabetes reports

    pub_type: 杂志文章,评审

    doi:10.1007/s11892-015-0637-y

    authors: Haw JS,Tantry S,Vellanki P,Pasquel FJ

    更新日期:2015-09-01 00:00:00

  • Transitioning safely from intravenous to subcutaneous insulin.

    abstract::The transition from intravenous (IV) to subcutaneous (SQ) insulin in the hospitalized patient with diabetes or hyperglycemia is a key step in patient care. This review article suggests a stepwise approach to the transition in order to promote safety and euglycemia. Important components of the transition include evalua...

    journal_title:Current diabetes reports

    pub_type: 杂志文章,评审

    doi:10.1007/s11892-015-0595-4

    authors: Kreider KE,Lien LF

    更新日期:2015-05-01 00:00:00

  • The forgotten role of glucose effectiveness in the regulation of glucose tolerance.

    abstract::Glucose effectiveness (SG) is the ability of glucose per se to stimulate its own uptake and to suppress its own production under basal/constant insulin concentrations. In an individual, glucose tolerance is a function of insulin secretion, insulin action and SG. Under conditions of declining insulin secretion and acti...

    journal_title:Current diabetes reports

    pub_type: 杂志文章,评审

    doi:10.1007/s11892-015-0605-6

    authors: Dube S,Errazuriz-Cruzat I,Basu A,Basu R

    更新日期:2015-06-01 00:00:00

  • Are analogue insulins superior to human insulin in clinical practice?

    abstract::Insulin analogues were designed to provide more physiologic pharmacokinetic and pharmacodynamic properties compared with human insulin. This article examines the literature over a 2-year period, focusing on studies directly comparing analogue and human insulin in controlled clinical trials and large observational stud...

    journal_title:Current diabetes reports

    pub_type: 杂志文章,meta分析

    doi:10.1007/s11892-010-0104-8

    authors: Freeman JS

    更新日期:2010-06-01 00:00:00

  • Update on the safety of thiazolidinediones.

    abstract::Diabetic patients are at increased risk for developing cardiovascular disease, and they constitute a large proportion of the global cardiovascular disease burden. Although multiple drugs exist for treating the hyperglycemia associated with diabetes, few have been shown to reduce cardiovascular risk. Great hope surroun...

    journal_title:Current diabetes reports

    pub_type: 杂志文章,评审

    doi:10.1007/s11892-010-0099-1

    authors: Lieb DC,McCall AL

    更新日期:2010-04-01 00:00:00

  • Memory T Cells in Type 1 Diabetes: the Devil is in the Detail.

    abstract:PURPOSE OF REVIEW:Therapies that target beta-cell antigen-specific T cells subsets have not been as successful in patients with type 1 diabetes as in mice. This might be explained by complexities in the repertoire of beta-cell antigen-specific T cells and the variety of T cell subsets involved in type 1 diabetes develo...

    journal_title:Current diabetes reports

    pub_type: 杂志文章,评审

    doi:10.1007/s11892-017-0889-9

    authors: Narsale A,Davies JD

    更新日期:2017-08-01 00:00:00

  • Progression of β-cell dysfunction in obese youth.

    abstract::The epidemic of childhood obesity has led to a remarkable increase in the prevalence of type 2 diabetes (T2D) among youth worldwide. The decreasing age at onset of T2D has alarming public health implications. In particular, the longer duration of the disease, as well as the faster onset and progression of T2D related ...

    journal_title:Current diabetes reports

    pub_type: 杂志文章,评审

    doi:10.1007/s11892-012-0347-7

    authors: Giannini C,Caprio S

    更新日期:2013-02-01 00:00:00

  • The CXCR1/2 Pathway: Involvement in Diabetes Pathophysiology and Potential Target for T1D Interventions.

    abstract::Although numerous chemokine/chemokine receptor pathways have been described to be implicated in the pathogenesis of type 1 diabetes (T1D), the CXCR1/2 axis has recently been proved to be crucial for leucocyte recruitment involved in insulitis and β cell damage. Multiple strategies blocking the CXCR1/2 pathway are avai...

    journal_title:Current diabetes reports

    pub_type: 杂志文章,评审

    doi:10.1007/s11892-015-0638-x

    authors: Citro A,Cantarelli E,Piemonti L

    更新日期:2015-10-01 00:00:00

  • Building Toward a Population-Based Approach to Diabetes Screening and Prevention for US Adults.

    abstract:PURPOSE OF REVIEW:Evidence-based treatments for prediabetes can prevent and delay the development of type 2 diabetes in adults. In this review, we propose a framework for population-based diabetes prevention that links screening and prevention activities across key stakeholders. We also discuss gaps in current practice...

    journal_title:Current diabetes reports

    pub_type: 杂志文章,评审

    doi:10.1007/s11892-018-1090-5

    authors: Bowen ME,Schmittdiel JA,Kullgren JT,Ackermann RT,O'Brien MJ

    更新日期:2018-09-19 00:00:00

  • The Charcot foot: medical and surgical therapy.

    abstract::Charcot neuro-osteoarthropathy (CN) is among the most devastating complications of neuropathy and now most commonly occurs in the feet of diabetic patients. Because it is relatively rare and because most patients and practitioners do not expect major bone pathology in the absence of significant pain, CN is often misdi...

    journal_title:Current diabetes reports

    pub_type: 杂志文章

    doi:10.1007/s11892-008-0077-z

    authors: Ulbrecht JS,Wukich DK

    更新日期:2008-12-01 00:00:00

  • Medical Devices in Obesity Treatment.

    abstract:PURPOSE OF REVIEW:Obesity is increasing at an alarming rate and now poses a global threat to humankind. In recent years, we have seen the emergence of medical devices to combat the obesity epidemic. These therapeutic strategies are discussed in this review dividing them into gastric and duodenal therapies. RECENT FIND...

    journal_title:Current diabetes reports

    pub_type: 杂志文章,评审

    doi:10.1007/s11892-019-1217-3

    authors: Ruban A,Doshi A,Lam E,Teare JP

    更新日期:2019-08-30 00:00:00

  • Benefit-to-Risk Balance of Weight Loss Interventions in Older Adults with Obesity.

    abstract:PURPOSE OF REVIEW:Obesity in the older adult is a burgeoning health epidemic that leads to increased morbidity, disability, and institutionalization. This review presents a brief overview of geriatric-specific consequences of obesity by highlighting the risks and benefits of intentional weight loss. RECENT FINDINGS:In...

    journal_title:Current diabetes reports

    pub_type: 杂志文章,评审

    doi:10.1007/s11892-019-1249-8

    authors: DiMilia PR,Mittman AC,Batsis JA

    更新日期:2019-11-04 00:00:00

  • Metabolic syndrome and cardiometabolic risk in PCOS.

    abstract::The cardiovascular risk associated with the polycystic ovary syndrome (PCOS) has recently attracted much interest. Women with PCOS are more likely to fulfill the diagnosis of the metabolic syndrome, a cluster of related cardiometabolic factors known to predict long-term risk of cardiovascular disease and type 2 diabet...

    journal_title:Current diabetes reports

    pub_type: 杂志文章,评审

    doi:10.1007/s11892-007-0012-8

    authors: Cussons AJ,Stuckey BG,Watts GF

    更新日期:2007-02-01 00:00:00

  • Technological Advancements in the Management of Type 2 Diabetes.

    abstract:PURPOSE OF REVIEW:The increasing prevalence of type 2 diabetes is driving the boundaries of clinical diabetes care outside of the traditional office setting. The purpose of this paper will be to review recent technological advances in the medical management of people with type 2 diabetes, spanning the spectrum of care ...

    journal_title:Current diabetes reports

    pub_type: 杂志文章,评审

    doi:10.1007/s11892-019-1278-3

    authors: Grant AK,Golden L

    更新日期:2019-12-20 00:00:00

  • Novel Therapeutics for Diabetes: Uptake, Usage Trends, and Comparative Effectiveness.

    abstract::The number of available therapies for treating type 2 diabetes has grown considerably in recent years. This growth has been fueled by availability of newer medications, whose benefits and risks have not been fully established. In this study, we review and synthesize the existing literature on the uptake, efficacy, saf...

    journal_title:Current diabetes reports

    pub_type: 杂志文章,评审

    doi:10.1007/s11892-016-0744-4

    authors: Ahuja V,Chou CH

    更新日期:2016-06-01 00:00:00

  • Sodium-Glucose Cotransporter Type 2 (SGLT-2) Inhibitors and Ketogenesis: the Good and the Bad.

    abstract:PURPOSE OF REVIEW:The micro/macrovascular complications of diabetes cause considerable morbidity and premature mortality. The SGLT2 inhibitors are the first diabetes medications with significant benefits on microvascular disease (nephropathy) and macrovascular cardiovascular disease. In this review, we evaluate one of ...

    journal_title:Current diabetes reports

    pub_type: 杂志文章,评审

    doi:10.1007/s11892-020-01359-z

    authors: Ekanayake P,Hupfeld C,Mudaliar S

    更新日期:2020-11-23 00:00:00

  • The Use of Non-insulin Agents in Gestational Diabetes: Clinical Considerations in Tailoring Therapy.

    abstract:PURPOSE OF REVIEW:To assess evidence to date for use of non-insulin agents in treatment of gestational diabetes mellitus. RECENT FINDINGS:There has been increasing interest in the use of non-insulin agents, primarily metformin and glyburide (which both cross the placenta). Metformin has been associated with less mater...

    journal_title:Current diabetes reports

    pub_type: 杂志文章,评审

    doi:10.1007/s11892-019-1243-1

    authors: Blair RA,Rosenberg EA,Palermo NE

    更新日期:2019-12-06 00:00:00

  • Genetics of diabetic nephropathy in the Pima Indians.

    abstract::Diabetic nephropathy is the leading cause of renal failure in industrialized countries. There is strong evidence that diabetic nephropathy is influenced by genetic factors. Studies in the Pima Indians as well as in other populations demonstrate that diabetic nephropathy aggregates in families. The hypothesis that the ...

    journal_title:Current diabetes reports

    pub_type: 杂志文章,评审

    doi:10.1007/s11892-001-0046-2

    authors: Imperatore G,Knowler WC,Nelson RG,Hanson RL

    更新日期:2001-12-01 00:00:00

  • Anti-VEGF therapy for diabetic macular edema.

    abstract::Vascular endothelial growth factor (VEGF) plays a pivotal role in the development of diabetic macular edema (DME), the leading cause of vision loss among working-aged individuals. A decade of clinical trials demonstrated that drugs that bind soluble VEGF restore the integrity of the blood-retinal barrier, resolve macu...

    journal_title:Current diabetes reports

    pub_type: 杂志文章,评审

    doi:10.1007/s11892-014-0510-4

    authors: Stewart MW

    更新日期:2014-08-01 00:00:00

  • The H-Reflex as a Biomarker for Spinal Disinhibition in Painful Diabetic Neuropathy.

    abstract:PURPOSE OF REVIEW:Neuropathic pain may arise from multiple mechanisms and locations. Efficacy of current treatments for painful diabetic neuropathy is limited to an unpredictable subset of patients, possibly reflecting diversity of pain generator mechanisms, and there is a lack of targeted treatments for individual pat...

    journal_title:Current diabetes reports

    pub_type: 杂志文章,评审

    doi:10.1007/s11892-018-0969-5

    authors: Lee-Kubli C,Marshall AG,Malik RA,Calcutt NA

    更新日期:2018-01-23 00:00:00

  • Air Pollution, Oxidative Stress, and Diabetes: a Life Course Epidemiologic Perspective.

    abstract:PURPOSE OF REVIEW:Ambient air pollution is strongly linked to cardiovascular and respiratory diseases. We summarize available published evidence regarding similar associations with diabetes across the life course. RECENT FINDINGS:We performed a life-course survey of the recent literature, including prenatal, gestation...

    journal_title:Current diabetes reports

    pub_type: 杂志文章,评审

    doi:10.1007/s11892-019-1181-y

    authors: Lim CC,Thurston GD

    更新日期:2019-07-19 00:00:00

  • Insights into the genetic susceptibility to type 2 diabetes from genome-wide association studies of glycaemic traits.

    abstract::Over the past 8 years, the genetics of complex traits have benefited from an unprecedented advancement in the identification of common variant loci for diseases such as type 2 diabetes (T2D). The ability to undertake genome-wide association studies in large population-based samples for quantitative glycaemic traits ha...

    journal_title:Current diabetes reports

    pub_type: 杂志文章,评审

    doi:10.1007/s11892-014-0551-8

    authors: Marullo L,El-Sayed Moustafa JS,Prokopenko I

    更新日期:2014-01-01 00:00:00

  • Heterogeneity in Obesity: Genetic Basis and Metabolic Consequences.

    abstract:PURPOSE OF REVIEW:Our review provides a brief summary of the most recent advances towards the identification of the genetic basis of specific aspects of obesity and the quantification of their consequences on health. We also highlight the most promising avenues to be explored in the future. RECENT FINDINGS:While obesi...

    journal_title:Current diabetes reports

    pub_type: 杂志文章,评审

    doi:10.1007/s11892-020-1285-4

    authors: Sulc J,Winkler TW,Heid IM,Kutalik Z

    更新日期:2020-01-22 00:00:00

  • Glucagon and type 2 diabetes: the return of the alpha cell.

    abstract::In normal physiology, glucagon from pancreatic alpha cells plays an important role in maintaining glucose homeostasis via its regulatory effect on hepatic glucose production. Patients with type 2 diabetes suffer from fasting and postprandial hyperglucagonemia, which stimulate hepatic glucose production and, thus, cont...

    journal_title:Current diabetes reports

    pub_type: 杂志文章,评审

    doi:10.1007/s11892-014-0555-4

    authors: Lund A,Bagger JI,Christensen M,Knop FK,Vilsbøll T

    更新日期:2014-12-01 00:00:00

  • The Genetic Contribution to Type 1 Diabetes.

    abstract:PURPOSE OF REVIEW:To provide an updated summary of discoveries made to date resulting from genome-wide association study (GWAS) and sequencing studies, and to discuss the latest loci added to the growing repertoire of genetic signals predisposing to type 1 diabetes (T1D). RECENT FINDINGS:Genetic studies have identifie...

    journal_title:Current diabetes reports

    pub_type: 杂志文章,评审

    doi:10.1007/s11892-019-1235-1

    authors: Bakay M,Pandey R,Grant SFA,Hakonarson H

    更新日期:2019-11-04 00:00:00

  • Periodontal disease and diabetes mellitus.

    abstract::Infections of the tissue surrounding the teeth (periodontitis) are usually caused by anaerobic gram-negative microorganisms. This infection causes destruction of the supporting alveolar bone and can lead to tooth loss. Removal of these microorganisms can slow or arrest the progression of periodontitis. Diabetes patien...

    journal_title:Current diabetes reports

    pub_type: 杂志文章,评审

    doi:10.1007/s11892-004-0011-y

    authors: Pucher J,Stewart J

    更新日期:2004-02-01 00:00:00

  • Pathophysiology of prediabetes.

    abstract::The term prediabetes refers to subjects with impaired fasting glucose and/or impaired glucose tolerance who are at increased risk for type 2 diabetes mellitus. Although both types of patients are at increased risk for developing type 2 diabetes mellitus and cardiovascular disease, they manifest distinct metabolic abno...

    journal_title:Current diabetes reports

    pub_type: 杂志文章,评审

    doi:10.1007/s11892-009-0032-7

    authors: Abdul-Ghani MA,DeFronzo RA

    更新日期:2009-06-01 00:00:00

  • The Evolving Role of the Cardiologist in the Management of Type 2 Diabetes.

    abstract:PURPOSE OF REVIEW:To evaluate the treatment of type 2 diabetes from a cardiologist's view. RECENT FINDINGS:A new era in the treatment of type 2 diabetes began for the cardiologist in 2015 with the publication of the EMPA-REG outcome trial finding a significant reduction in CV death with empagliflozin (oral sodium-gluc...

    journal_title:Current diabetes reports

    pub_type: 杂志文章,评审

    doi:10.1007/s11892-018-1114-1

    authors: Chilton RJ,Gallegos KM,Silva-Cardoso J,Oliveros R,Pham S

    更新日期:2018-11-08 00:00:00